{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/regn-stockholders-interested-in-leading-the-class-action-against-regeneron-pharmaceuticals-inc-should-contact-robbins-llp-for-information-about-recovering-their-losses-302855747.html", "message": "News view counter 893873 successfully enlarged"}